Production (Stage)
Helius Medical Technologies, Inc.
HSDT
$4.18
-$0.24-5.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.25% | -32.68% | 30.19% | 12.15% | 27.40% |
| Total Depreciation and Amortization | -59.06% | -62.96% | -61.88% | -54.76% | -45.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 247.22% | 145.80% | -171.63% | 30.13% | -429.41% |
| Change in Net Operating Assets | 61.69% | 97.43% | -661.62% | -51.57% | 35.99% |
| Cash from Operations | -13.19% | -6.00% | -1.63% | 12.75% | 20.21% |
| Capital Expenditure | 100.00% | 82.76% | 66.67% | 44.00% | 55.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 82.76% | 66.67% | 44.00% | 55.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 101.61% | 173.64% | 669.04% | -76.30% | -85.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2,744.20% | 5,990.77% | 10,655.56% | 621.17% | 81.79% |
| Cash from Financing | 256.22% | 545.68% | 1,565.05% | -52.58% | -85.80% |
| Foreign Exchange rate Adjustments | -- | -300.00% | -50.00% | 100.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.16% | 56.29% | 69.01% | -141.53% | -253.12% |